Harry Lambert
Harry Lambert practices in the areas of product liability, clinical negligence, and personal injury. He is recognised as a leading junior in the directories and in recent years has been involved in some of the most high profile and heavyweight litigation in the field.
His aim, in short, is to combine excellence with approachability; intellectual rigour with a down-to-earth attitude and common sense.
He provides advice with meticulous detail (“a very detailed and focused counsel, who never misses a trick” – Legal 500) but if matters go to trial “Harry fights his corner hard” (Chambers & Partners).
Harry is one of the leading Product Liability juniors at the Bar. He is ranked in Band 2 in Legal 500 where he is described as “a thorough, hardworking barrister” with a “superb intellect, [who] outshines his contemporaries.” He is the author of the chapter on product liability and multi-party actions in 18th edition of Bullen & Leake and was asked by the Bar Council to write its paper on Brexit and the Consumer Protection Act.
Harry has been instructed in most of the big product liability cases of recent years including: Metal on Metal Hips, Thalidomide and the ongoing Seroxat litigation in which Harry conducted a hearing against two QCs (Charles Gibson QC and Malcolm Sheehan QC) and a junior more senior than him. It was listed as one of the Lawyer Magazine “Top 20 cases of 2019”.